New MuscleSCS device aims to ease stubborn back pain
NCT ID NCT07215104
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new way to stimulate muscles through the spinal cord (called MuscleSCS) to help people with chronic low back pain. It includes 30 adults who already have a spinal cord stimulator and get good pain relief from it. The goal is to see if MuscleSCS can safely improve pain, disability, and quality of life even more.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- MuscleSCS (spinal cord induced muscle stimulation device)
- What this could lead to
- If it works, this could offer a new way to reduce chronic low back pain for people who already use spinal cord stimulation.
- What could go wrong
- This is a small, early-stage study with only 30 participants, so results may not apply to everyone. The device is already in use, so risks are likely low but unknown for this specific method.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC LOW-BACK PAIN (CLBP) are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
WVUM/Thomas Hospitals (Saint Francis Hospital) Spine and Nerve Center
RECRUITINGCharleston, West Virginia, 25301, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a simple test pinpoint the true source of chronic back pain?
- Could a glucose drink help explain chronic back pain?
- Can water workouts beat land exercises for back pain?
- Spinal stretch may unlock relief for stubborn back pain
- Music before rehab: could a specially designed playlist ease fear of movement and boost recovery?
- Stronger back muscles may ease chronic pain — a trial puts the idea to the test